Eubiotics Market is expected to grow at a moderate rate during the forecast period 2019-2025. Eubiotics supports to maintain the healthy balance of the microbiota in the gastrointestinal tract. There are several kinds of eubiotics for both animal and human use that enables to improve gut health and immune systems. This includes prebiotics, probiotics, exogenous enzymes, organic acids, essential oils, and others. The two main requirements in animal feed industry include maintaining health and promoting growth. The use of eubiotics keeps the optimal balance of microflora, referred to as eubiosis in the gastrointestinal tract of animals. As a result, the presence of the optimal balance of microflora optimizes absorption of nutrients, which promotes better animal health.

Moreover, as reported by the American Medical Association (AMA), antibiotic/ antimicrobial resistance is considered to be one of the major threats to human health. For instance, according to the World Health Organization (WHO), the widespread occurrence of antibiotic resistance reported among 500,000 people across 22 countries. Additionally, according to the Centers for Disease Control & Prevention (CDC), in the US, more than 2 million people get an antibiotic-resistant infection annually and nearly 23,000 people die. A growing number of infections, including salmonellosis, gonorrhea, pneumonia, and tuberculosis are highly difficult to treat. The antibiotics that are used for the treatment of these infections become less effective. Antibiotic microbial resistance is growing to dangerously high levels across several countries.

In this context, a global action plan on antibiotic resistance was sanctioned in 2015. This plan is intended to ensure the prevention and treatment of infectious diseases with effective and safe medicines. It has certain strategic objectives, such as reduce the incidence of infection and improving awareness and understanding of antimicrobial resistance. This, in turn, is encouraging the demand for eubiotics, such as probiotics, prebiotics, and essential oils. The use of probiotic products, such as yogurts, and chocolates can support to rebalance the microflora that is naturally found in the gut. It can also reduce the risk of developing gastrointestinal infections. Some probiotic strains with essential antibiotic resistance could be helpful to restore gut microbiota after antibiotic treatment. Hence, probiotics can be an effective alternative for the prevention and treatment of such bacterial infections. Other crucial factors boosting the demand for eubiotics products include increasing demand for dietary supplements and the ban on antibiotic use for animals.

The global eubiotics market is segmented on the basis of type, application, and end-user. Based on the type, the market is further classified into probiotics, prebiotics, exogenous enzymes, organic acids, essential oils, and others. Based on application, the market is further classified into feed additives, food & beverages and dietary supplements. Based on end-user, the market is further classified into animals and humans. The increasing number of countries banning the use of antibiotic growth promoters has primarily led the demand for potential alternatives to support reducing the harmful effects of bacterial diseases. Eubiotics are primarily used to maintain intestinal eubiosis in livestock animals to improve performance and health status. This, in turn, is encouraging the adoption of eubiotics in animals.

Geographically, the global eubiotics market is segmented into North America, Europe, Asia-Pacific, and RoW. The factors contributing to the growth of the market in North America include the prevalence of antimicrobial resistance and significant meat consumption in the region. Europe is gaining traction in the market due to the ban on the use of antibiotics in animal feed. Moreover, Asia-Pacific is estimated to show potential growth due to increasing awareness for gastrointestinal infections and significant livestock population in the region.

The major companies that are involved in the manufacturing of eubiotics products include Koninklijke DSM NV, Cargill, Inc., E.I. du Pont de Nemours, Novozymes A/S, and Co., and Abbott Laboratories, Inc. These companies follow several strategies, such as merger and acquisitions, product launches, partnership and collaborations to increase market share globally. For instance, in September 2018, Koninklijke DSM NV and Novozymes A/S introduced Balancius, a significant advancement in poultry nutrition that significantly increases digestibility and feeds efficiency in boilers. This is the first and only microbial muramidase that functions to increase sustainable product yield and improve feed efficiency. This solution can contribute to the growth and welfare of animals that is achieved by removing bacterial cell debris from the gut of chicken.

Research Methodology

The market study of global eubiotics market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in our reports.

Secondary Sources Include

• Financial reports of companies involved in the market
• Authentic Public Databases such as CDC, Council for Responsible Nutrition (CRN) and so on.
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The report is intended for government and private companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global eubiotics market is segmented on the basis of regional outlook and following segments:

• Global Eubiotics Market Research and Analysis by Type
• Global Eubiotics Market Research and Analysis by Application
• Global Eubiotics Market Research and Analysis by End-User
• Global Eubiotics Market Research and Analysis by Region

The Report Covers

• Comprehensive research methodology of the global eubiotics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global eubiotics market.
• Insights about market determinants which are stimulating the global eubiotics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.